Anne Marie Sabrina Wehbe

Array ( [id] => 11225526 [patent_doc_number] => 09453242 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-27 [patent_title] => 'Method and culture medium for preparing mammalian ovum or embryo in which zona pellucida has been thinned or eliminated, and method for fertilization using mammalian ovum prepared by same method' [patent_app_type] => utility [patent_app_number] => 13/822171 [patent_app_country] => US [patent_app_date] => 2011-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15340 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13822171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239478 [patent_doc_number] => 08604271 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Humanized NSG mouse, method of producing the same and use thereof' [patent_app_type] => utility [patent_app_number] => 13/227233 [patent_app_country] => US [patent_app_date] => 2011-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5368 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13227233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8516704 [patent_doc_number] => 20120316112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'RESCUE OF PHOTORECEPTORS BY INTRAVITREAL ADMINISTRATION OF AN EXPRESSION VECTOR ENCODING A THERAPEUTIC PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/212078 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11285 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13212078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7652072 [patent_doc_number] => 20110301341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'MODIFIED ORGANS AND CELLS FOR XENOTRANSPLANTATION' [patent_app_type] => utility [patent_app_number] => 13/211040 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10460 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301341.pdf [firstpage_image] =>[orig_patent_app_number] => 13211040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9280271 [patent_doc_number] => 20140030239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'HIGHLY FUNCTIONALIZED STEM CELL/PROGENITOR CELL BY APE1 GENE TRANSFECTION' [patent_app_type] => utility [patent_app_number] => 13/816107 [patent_app_country] => US [patent_app_date] => 2011-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9443 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670211 [patent_doc_number] => 20110319480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Method of Inducing and/or Enhancing an Immune Response to Tumor Antigens' [patent_app_type] => utility [patent_app_number] => 13/196704 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11154 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13196704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9645478 [patent_doc_number] => 20140223592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'PIG MYOSTATIN GENE LOCUS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/128995 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6122 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8220825 [patent_doc_number] => 20120135031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'METHOD OF ENHANCING AN IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 13/169159 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 29572 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13169159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8896963 [patent_doc_number] => 08476485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Non-human animal model for amyotrophic lateral sclerosis (ALS) with loss-of-TDP-43 function' [patent_app_type] => utility [patent_app_number] => 13/166147 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 9774 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13166147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9989924 [patent_doc_number] => 09035128 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-19 [patent_title] => 'Hybrid light chain mice' [patent_app_type] => utility [patent_app_number] => 13/166200 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 26403 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13166200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670210 [patent_doc_number] => 20110319479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA' [patent_app_type] => utility [patent_app_number] => 13/163776 [patent_app_country] => US [patent_app_date] => 2011-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16900 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13163776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7588859 [patent_doc_number] => 20110283370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'MOUSE MODEL FOR DEPRESSION, SCHIZOPHRENIA AND ALZHEIMER\'S DISEASE AND THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/161817 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4202 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0283/20110283370.pdf [firstpage_image] =>[orig_patent_app_number] => 13161817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9312105 [patent_doc_number] => 08653324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'TetO-p16 transgenic mice' [patent_app_type] => utility [patent_app_number] => 13/157477 [patent_app_country] => US [patent_app_date] => 2011-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 48 [patent_no_of_words] => 7003 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13157477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7658697 [patent_doc_number] => 20110307966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Mice Expressing Human Voltage-Gated Sodium Channels' [patent_app_type] => utility [patent_app_number] => 13/155491 [patent_app_country] => US [patent_app_date] => 2011-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19257 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0307/20110307966.pdf [firstpage_image] =>[orig_patent_app_number] => 13155491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8059875 [patent_doc_number] => 20110247087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Regulation of endogenous gene expression in cells using zinc finger proteins' [patent_app_type] => utility [patent_app_number] => 13/068877 [patent_app_country] => US [patent_app_date] => 2011-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29834 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20110247087.pdf [firstpage_image] =>[orig_patent_app_number] => 13068877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7743133 [patent_doc_number] => 20120021409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Common Light Chain Mouse' [patent_app_type] => utility [patent_app_number] => 13/093156 [patent_app_country] => US [patent_app_date] => 2011-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27543 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021409.pdf [firstpage_image] =>[orig_patent_app_number] => 13093156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511657 [patent_doc_number] => 20110257367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'ALLOGENEIC VACCINE AND METHODS TO SYNTHESIZE SAME' [patent_app_type] => utility [patent_app_number] => 13/085047 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 41441 [patent_no_of_claims] => 130 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257367.pdf [firstpage_image] =>[orig_patent_app_number] => 13085047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573057 [patent_doc_number] => 20110268713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Variants of Ancestral Uricases and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/083011 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16275 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268713.pdf [firstpage_image] =>[orig_patent_app_number] => 13083011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696715 [patent_doc_number] => 20110229875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY' [patent_app_type] => utility [patent_app_number] => 13/079269 [patent_app_country] => US [patent_app_date] => 2011-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4544 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229875.pdf [firstpage_image] =>[orig_patent_app_number] => 13079269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662314 [patent_doc_number] => 08809290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells' [patent_app_type] => utility [patent_app_number] => 13/078119 [patent_app_country] => US [patent_app_date] => 2011-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 63 [patent_no_of_words] => 28097 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13078119 [rel_patent_id] =>[rel_patent_doc_number] =>)